Immunogenicity and Reactivity of Novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with Sera from Experimentally and Naturally Infected Animals by Bannantine, John et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Publications from USDA-ARS / UNL Faculty U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska 
2010 
Immunogenicity and Reactivity of Novel Mycobacterium avium 
subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 
Proteins with Sera from Experimentally and Naturally Infected 
Animals 
John Bannantine 
USDA-ARS, john.bannantine@ars.usda.gov 
Avery L. Paulson 
University of Nebraska - Lincoln, avery.pailson@huskers.unl.edu 
Ofelia Chacon 
University of Nebraska - Lincoln 
Robert J. Fenton 
University of Nebraska - Lincoln, rfenton2@unl.edu 
Denise Zinniel 
University of Nebraska-Lincoln, dzinniel2@unl.edu 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub 
Bannantine, John; Paulson, Avery L.; Chacon, Ofelia; Fenton, Robert J.; Zinniel, Denise; McVey, David S.; 
Smith, David R.; Czuprynski, Charles J.; and Barletta, Raúl G., "Immunogenicity and Reactivity of Novel 
Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with 
Sera from Experimentally and Naturally Infected Animals" (2010). Publications from USDA-ARS / UNL 
Faculty. 2366. 
https://digitalcommons.unl.edu/usdaarsfacpub/2366 
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research 
Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion 
in Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of 
Nebraska - Lincoln. 
Authors 
John Bannantine, Avery L. Paulson, Ofelia Chacon, Robert J. Fenton, Denise Zinniel, David S. McVey, David 
R. Smith, Charles J. Czuprynski, and Raúl G. Barletta 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
usdaarsfacpub/2366 
CLINICAL AND VACCINE IMMUNOLOGY, Jan. 2011, p. 105–112 Vol. 18, No. 1
1556-6811/11/$12.00 doi:10.1128/CVI.00297-10
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
Immunogenicity and Reactivity of Novel Mycobacterium avium subsp.
paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins
with Sera from Experimentally and Naturally Infected Animals†
John P. Bannantine,1 Avery L. Paulson,2 Ofelia Chacon,2 Robert J. Fenton,2 Denise K. Zinniel,2
David S. McVey,2 David R. Smith,2 Charles J. Czuprynski,3 and Raúl G. Barletta2*
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Mycobacterium avium subsp. paratuberculosis causes Johne’s disease (JD) in ruminants. Development of
genetic tools and completion of the M. avium subsp. paratuberculosis genome sequencing project have expanded
the opportunities for antigen discovery. In this study, we determined the seroreactivities of two proteins
encoded at the 5 and 3 regions of the MAP1152-MAP1156 gene cluster. MAP1152 encodes a PPE protein, and
MAP1156 encodes a diacylglycerol acyltransferase involved in triglyceride metabolism and classified in the
uncharacterized protein family UPF0089. Recombinant MAP proteins were overproduced and purified from
Escherichia coli as maltose-binding protein (MBP) fusions. Immunoblotting analysis indicated that both
MAP1152 and MAP1156 displayed reactivity against sera of mice and rabbits immunized with live M. avium
subsp. paratuberculosis cells and against samples from naturally infected cattle. In immunoblot assays,
MAP1156 yielded a stronger positive signal than MAP1152 against sera from cattle with JD. An enzyme-linked
immunosorbent assay for the recombinant proteins was developed and used to test preclassified positive and
negative serum samples from naturally infected and noninfected cattle. Samples, with one exception, displayed
no seroreactivity against the MBP-LacZ fusion protein (P > 0.05), the negative-control antigen. MAP1152
displayed seroreactivity against all positive sera but no seroreactivity to the negative sera (P < 0.01). MAP1156
displayed stronger and more variable reactivity than MAP1152, but significant differences were observed
between noninfected and infected cattle (P < 0.05). Otherwise, degrees of reactivity followed the same trend as
the positive reference antigen. In conclusion, both proteins are immunogenic in mice and rabbits, and M. avium
subsp. paratuberculosis-infected cattle mount a humoral response to both MAP1152 and MAP1156 cross-
reactive epitopes. These findings have potential applications to diagnostics, vaccine production, and elucida-
tion of the immunopathogenesis of JD.
Mycobacterium avium subsp. paratuberculosis, one of the
slowest-growing mycobacteria (28), is the etiologic agent of
Johne’s disease (JD) in ruminants (11, 24). JD is a chronic
enteritis with significant economic impact and worldwide dis-
tribution (23, 51, 53, 57). A JD regression model estimates that
losses to the dairy industry range from $40 to $227 per inven-
toried cow per year (24, 40). JD has lower prevalence in beef
herds, but this disease still has a negative impact on trade (38,
42, 60). Concerns for human health have also been raised,
since M. avium subsp. paratuberculosis has the potential to be
a zoonotic and/or food-borne pathogen, as evidenced by its
possible linkage to Crohn’s disease (6, 8, 9, 21).
The physiology and pathogenesis of M. avium subsp. para-
tuberculosis have been reviewed (24, 61). Neonates and juve-
nile animals are the most susceptible to infection. Disease
progression is classified into four stages: silent infection and
subclinical, clinical, and advanced clinical disease (61). Despite
the progress made in the analysis of mechanisms of pathogen-
esis, a diagnostic test of high sensitivity and specificity for
detection of subclinically infected animals has not been devel-
oped (15, 19, 27, 33, 34, 39, 50). In this situation, most diseased
animals escape detection, especially during early infection.
Likewise, current vaccines against JD are highly regulated,
have poor efficacy, and interfere with diagnostic tests against
bovine tuberculosis (5, 10, 20, 23, 55).
The information obtained from the completed M. avium
subsp. paratuberculosis genome sequencing project ushered in
the development of new tools for diagnosis and disease control
(29). In the context of our study, approximately 1% of the M.
avium subsp. paratuberculosis genome encodes members of the
PE (Pro-Glu) and PPE (Pro-Pro-Glu) protein families, so de-
nominated by their characteristic motifs at their N-terminal
domains. These genes were initially discovered in the Myco-
bacterium tuberculosis genome, which dedicates approximately
10% of its coding capacity to these elements. Cole et al. hy-
pothesized that the PE and PPE families may have immuno-
logical importance, being the main source of antigenic varia-
tion (14, 52, 56). This quantitative difference in coding capacity
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seems to be rooted in the evolutionary expansion of these
families as microorganisms of the Mycobacterium tuberculosis
complex diverged from the M. avium group (22). M. avium
subsp. paratuberculosis possesses only the ancestral members
of these families. Thus, functional analyses of these proteins
are significant for the development of vaccines and diagnostics,
as well as for the understanding of their roles in JD pathogen-
esis.
This study focused on the MAP1152-MAP1156 gene cluster,
as the Tn5367 transposon insertion in the colony morphology
M. avium subsp. paratuberculosis strain K-10 mutant with an
attenuated phenotype in bovine macrophages (31), has now
been mapped ca. 0.6 kb upstream from MAP1152. To evaluate
the potential role of this gene cluster in M. avium subsp. para-
tuberculosis immunobiology, we performed further bioinfor-
matic analysis and determined the reactivities of MAP1152 and
MAP1156 against sera from mice and rabbits immunized with
live M. avium subsp. paratuberculosis and against samples from
naturally infected cattle.
MATERIALS AND METHODS
Cloning, expression, and purification of M. avium subsp. paratuberculosis
proteins in Escherichia coli. MAP1152 and MAP1156 coding sequences were
amplified from M. avium subsp. paratuberculosis K-10 genomic DNA and cloned
into the pMAL-c2 translational fusion expression vector using the primers 5-A
TCCTCTAGAATGGATTTCGGGTCGTTACCGC-3 and 5-GCGCAAGCT
TCTATTTCGCGTTCGGCG-GAATG-3 for MAP1152 and 5-ATCCTCTAG
AATGAAACGGCTTTCGAGTGTCG-3 and 5-GCGCAAGCTTCAGCCGG
TCTCGCCCGCGGCG-3 for MAP1156. Both primer pairs amplified the
corresponding full-length coding sequence. The vector and amplification prod-
ucts were each digested with XbaI and HindIII. Following overnight ligation at
4°C, the products were transformed into E. coli DH5 and selected on LB agar
plates containing 0.10 mg/ml ampicillin. Drug-resistant colonies were screened
by PCR using the amplification primers, and plasmid DNA for sequencing
analysis was produced from positive colonies to confirm each clone. E. coli
protein lysates from verified clones were prepared as previously described (47).
Proteins used in this study were expressed and purified as recombinant maltose-
binding protein (MBP) N-terminal fusions (e.g., LacZ, MAP1152, and
MAP1156; referred to here by these short names, with the understanding that all
recombinant proteins used in the experiments were fusion products). These
MBP-tagged recombinant proteins were overexpressed by induction of 1.0-liter
LB broth cultures with 0.3 mM isopropyl--D-thiogalactopyranoside (Sigma
Chemical Company, St. Louis, MO) for 2.5 h with shaking at 37°C. E. coli cells
were harvested by centrifugation at 4,000  g and resuspended in column buffer,
and the cell suspension was subjected to a freeze-thaw cycle at 20°C and
sonicated under conditions described previously (1). The resulting crude extracts
were purified by affinity chromatography with an amylose resin (New England
Biolabs). Purified protein yields were determined from eluted fractions with a
NanoDrop spectrophotometer set at 280 nm. The most concentrated fractions
were pooled and dialyzed in Slide-A-Lyzer cassettes (Pierce Biotechnology Inc.,
Rockford, IL) immersed in 1.5 liters of phosphate-buffered saline (PBS; 150 mM
NaCl, 10 mM Na2HPO4; pH 7.4) with three exchanges at 4°C. Purified protein
aliquots were stored at 20°C. After thawing the aliquots, protein yield was
reassessed by a modified Lowry assay using bovine serum albumin (BSA) as the
standard. E. coli DH5 harboring the parental plasmid pMAL-c2 was expressed,
purified, and used as a control. Purified protein from this control strain consists
of an MBP fusion (overall mass, 42 kDa) with the LacZ alpha peptide (8 kDa).
Each recombinant protein was further evaluated by using GelCode blue (Pierce
Biotechnology Inc., Rockford, IL)-stained SDS-PAGE gels to assess purity and
expected sizes.
Electrophoresis and immunoblot analysis. Gel electrophoresis was performed
using 12% (wt/vol) polyacrylamide gels. Electrophoretic transfer of proteins onto
pure nitrocellulose was carried out using a TransBlot cell (Bio-Rad Laboratories,
Richmond, CA) with sodium phosphate buffer (25 mM; pH 7.8) at 0.8 A for 90
min. After transfer, filters were blocked with PBS plus 2% BSA and 0.1% Tween
20 (BSA-PBST). Cattle serum samples (Table 1) were diluted 1:500 in BSA-
PBST, and the rabbit and mouse sera were diluted 1:1,000. As necessary, sub-
clinical (stage 2) versus clinical (stage 3) infections were assessed by fecal counts,
as described previously (62). For detection of MBP, a high-titer murine anti-
MBP monoclonal antibody was diluted 1:10,000. Each blot was incubated at
room temperature for 2 h with gentle rocking. After three washes in PBS plus
0.1% Tween 20, blots were incubated for 1.5 h in a horseradish peroxidase
(HRP)-labeled goat anti-bovine detection antibody that was obtained from
Southern Biotechnology and diluted 1:10,000 in PBS-BSA. The blots were again
washed three times as described above and developed for chemiluminesence
using Supersignal detection reagents (Pierce).
Quantitative analysis of band intensities on immunoblots. Band intensity was
determined using the Adobe Photoshop CS4 extended application measurement
tool. This version has the ability to record pixel gray values using the default
measurement scale (1 pixel  1 pixel). Each spot was measured identically by
using a defined window area. Values were exported into a spreadsheet for further
analysis. The background statistics were calculated by determining the means
and standard deviations of the bands that had the least signal intensity within
each output graph. Each intensity score was normalized to this calculated back-
ground intensity.
ELISA. An enzyme-linked immunosorbent assay (ELISA) was developed to
quantify the reactivities of MAP1152 and MAP1156 proteins with a subset of
serum samples from cattle with known exposure to M. avium subsp. paratuber-
culosis (Table 1). Antigen (0.010 mg per well) was bound to BD Falcon Pro-Bind
96-well plates overnight at 4°C. Antigen was diluted in 1.0 M sodium carbonate
buffer (pH 9.8), and 0.1 ml of solution was bound in each well. After overnight
incubation, the plate was washed five times with PBS and blocked with 0.3 ml
BSA-PBST for 2 to 3 h at room temperature. The ELISA was performed as per
the instructions provided with the HerdChek ELISA kit (Idexx Laboratories,
Westbrook, ME). Briefly, sera were diluted 1:25 in either BSA-PBST or the
buffer supplied by Idexx containing Mycobacterium phlei antigen for clarification.
Diluted serum was applied (0.1 ml) to each well and incubated for 30 min at
room temperature, plates were washed five times with PBS, and secondary
antibody conjugate (HRP-conjugated rabbit anti-bovine IgG) was applied (0.1
ml/well) and incubated for 30 min at room temperature. After additional washing
steps, 0.1 ml tetramethylbenzadiene (TMB) was added, and the subsequent
reaction was stopped with the supplied SDS Stop solution as the appropriate
color developed. Absorbance was read at 650 nm with a Molecular Devices
Vmax kinetic microplate reader and translated with the xChek software from
Idexx. The sample-to-positive (S/P) ratios for each antigen were calculated based
on optical density (OD) values, as follows: [(OD of serum sample  OD of
negative-control serum)]/[(OD of positive-control serum  OD of negative-
control serum)], as described for the Idexx HerdChek assay. Statistical analysis of
ELISA results was performed using SAS 9.2 for Windows (SAS Institute Inc.,
Cary, NC). To compare average absorbances of all seropositive cattle samples to
TABLE 1. Cattle serum samples used in the study
Serum sample
Original
classification
(Idexx test)
Type of infection Source
Cow 183  Natural (JD) NADCa
Cow 2075  Natural (JD) NADC
Cow 184  Natural (JD) NADC
Cow 805  Natural (JD) NADC
Cow 45  Natural (JD) NADC
Cow 193  Experimental, with M.
avium hominissius
NADC
Cow 2291  Experimental, with M.
bovis strain 95-1315
NADC
Cow 47  Natural (JD) NADC
Positive controlb  Natural (JD) Idexx Laboratories
EDNA  Natural (JD) NADC
Cow 308  Natural (JD) NADC
2010-07  Natural (JD) Nebraska dairyc
Negative controld  None Idexx Laboratories
J53-90  None Nebraska beef herdc
Cow 559  None NADC
3438-08  None Nebraska dairyc
a NADC, National Animal Disease Center, Ames, IA.
b Positive-control serum provided with the Idexx kit, derived from a single
naturally infected Holstein cow (Idexx Technical Service).
c Dairy or beef cattle of the University of Nebraska Lincoln Veterinary Diag-
nostic Center, Lincoln, NE.
d Negative-control serum provided with the Idexx kit, derived from a single
Holstein cow residing in a herd that tested negative for paratuberculosis by
whole-herd testing over multiple years (Idexx Technical Service).
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the seronegative group, mixed model regression (MIXED) analysis was per-
formed, factoring the repeated measures for day and serum sample. To evaluate
within- and between-antigen serum combination differences, the generalized
linear mixed models regression (GLIMMIX) analysis was used. A P value of
0.05 was considered significant.
RESULTS
Bioinformatic analysis of the MAP1152-MAP1156 gene
cluster. Nine PE and 37 PPE protein genes are scattered
around the M. avium subsp. paratuberculosis chromosome (Fig.
1). The major PPE cluster is at 1.66 Mb in the clockwise
direction in the published genome sequence (29) and com-
prises MAP1514, encoding a PE protein, and six PPE genes.
The MAP1152-MAP1156 region of interest for this study is the
second major cluster and is located 1.21 Mb in the clockwise
direction. This region encodes the PPE proteins MAP1152
(40.8 kDa), MAP1153 (45.8 kDa), and MAP1155 (32.3 kDa)
(Fig. 1, inset). This region also encodes a putative open reading
frame (ORF) of unknown function (MAP1154; 11.8 kDa) and
MAP1156 (50.7 kDa), a member of the uncharacterized
protein family (UPF0089) (http://pfam.sanger.ac.uk/family
/PF03007). The M. avium subsp. paratuberculosis genome en-
codes nine UPF0089 family genes, and MAP1156 is the only
member that is immediately adjacent to a PPE gene (Fig. 1).
This cluster does not encode a PE protein sequence.
It is tempting to speculate that genes in the MAP1152-
MAP1156 region are organized in a functional unit, since
ORFs further upstream and downstream are transcribed from
the complementary strand with short (e.g., 200-bp) inter-
genic regions. However, more stringent predictions indicate
that only MAP1152 and MAP1153 are organized in a true
operon with an estimated probability that a pair of genes is in
the same operon (pOp) value of 0.842 (http://www
.microbesonline.org/operons/gnc262316.html) (44, 45). None-
theless, the genes in this cluster may comprise more than one
operon.
The proximal (MAP1152) and distal (MAP1156) ORFs in
the cluster were selected for immunological tests of humoral
immunity in infected and noninfected animals. MAP1152 en-
codes a typical PPE protein of 416 amino acids with a pre-
dicted molecular mass of 40.8 kDa (Table 2). Protein structure
analysis predicts for the best model three trans-membrane he-
lices (48; http://www.predictprotein.org), consistent with a sur-
face or membrane localization, as shown for other PPE pro-
teins (7, 25, 32, 36, 43). MAP1156 is a protein of 464 amino
acids with a predicted molecular mass of 50.7 kDa. Protein
structural analysis for the best fit model predicts one trans-
membrane helix, suggesting surface localization (48). Both
MAP1152 and MAP1156 have homologous sequences in both
M. avium subsp. paratuberculosis and other mycobacterial ge-
nomes. Further bioinformatic analysis of the ORFs in the
cluster is presented in Table 2.
FIG. 1. Genomic map of PE, PPE, and UPF genes in M. avium
subsp. paratuberculosis K-10 (MAP). Genes encoding PE (shown as
bars inside of the circular chromosome), PPE (bars crossing the cir-
cular chromosome), and UPF (bars outside the circle) protein family
members are shown. No PGRS protein-coding sequences were found.
(Inset) MAP1152-MAP1156 genomic region, indicating genes encod-
ing PPE proteins MAP1152, MAP1153, and MAP1155 (black boxes),
UPF protein MAP1156 (gray box), hypothetical protein MAP1154
(dark patterned box), and MAP1150c and MAP1151c (light patterned
boxes). Arrowed boxes indicate the direction of transcription.
TABLE 2. Characterizations of ORFs MAP1152 to MAP1156
ORF Size(no. of aa, mass)a H37Rv homolog
b/E-valuec Domain, motifa,c Comment(s)d
MAP1152 416, 40.7 Rv1808 (PPE32)/8.0 E78 PPE, GxxSVPxxW Three MH
MAP1153 454, 45.7 Rv1809 (PPE33)/1.0 E84 PPE, GxxSVPxxW Coding sequence starts 7 bp downstream
from MAP1152; three MH
MAP1154 117, 11.7 Rv1810/8.0 E19 DUF732 superfamily Hypothetical protein; no MH
MAP1155 320, 32.2 Rv1807 (PPE31)/4.0 E24 PPE, GxxSVPxxW Attenuating mutation in M. tuberculosis
homolog (49); two MH
MAP1156 464, 50.6 Rv1425/0.0 UPF0089 M. tuberculosis homolog encodes enzyme
with low TGS activity (16); possibly
one MH
a Data are based on National Center for Biotechnology Information (NCBI) database output. Sizes are reported as the number of amino acids (aa) and as molecular
mass (in kilodaltons).
b Data entries based on the Pfam database (http://pfam.sanger.ac.uk/family). Most homologous M. tuberculosis proteins are not necessarily orthologs (22).
c E-values (determined using the Blastp suite) are formatted as described in the BLAST help manual (http://www.ncbi.nlm.nih.gov/blast/blast_help.shtml).
d MH, membrane helices (determined via the PredictProtein server 	http://www.predictprotein.org
 for protein analysis 	PHDhtm output
).
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Seroreactivity of recombinant proteins by immunoblot anal-
ysis. Purified recombinant proteins MAP1152 and MAP1156
were subjected to SDS-PAGE and immunoblot analyses.
Equal amounts of both proteins were examined by SDS-PAGE
to verify that their migration corresponded with their molecu-
lar size (Fig. 2, SDS-PAGE). Both fusion proteins migrated to
the expected positions between the 75-kDa and 100-kDa pro-
tein markers, with MAP1156 (90.6 kDa) located slightly higher
than MAP1152 (82.8 kDa). Likewise, LacZ (42 kDa) mi-
grated to a position below the 50-kDa marker. These data
indicate that the MBP method resulted in protein preparations
of the necessary purity and yield to carry out further testing.
MAP1156 did show multiple bands, in contrast to the discrete
single bands observed for MAP1152 and LacZ. Immunoblot
quality control analysis was also performed, using a monoclo-
nal antibody developed to the MBP affinity tag. All three MBP
fusion proteins were detected by this antibody (Fig. 2, MBP
MAb). The additional bands observed in the MAP1156 prep-
aration likely represent degradation products with the same N
terminus, as the fast-migrating bands reacted also with the
MBP monoclonal antibody.
The immunogenicity of the recombinant proteins was tested
by immunoblotting using immune mouse (C57BL/6) or rabbit
(New Zealand White) serum from animals immunized with a
live preparation of M. avium subsp. paratuberculosis, as de-
scribed previously (2). The mouse serum displayed little to no
reactivity to MAP1152 but strong reactivity to MAP1156, with
the most intense band migrating between the 50- and 75-kDa
markers (Fig. 2, mouse 160). The rabbit immune serum
showed strong reactivities to both proteins (Fig. 2, rabbit 273).
Reactivity against the LacZ antigen carrying the MBP tag was
used as a negative control. The mouse serum displayed no
MBP-LacZ reactivity (Fig. 2, mouse panel, lane 4), and only a
weak reaction was observed with the rabbit serum (Fig. 2,
rabbit panel, lane 4). Thus, the MBP tag yielded no to minimal
reactivity in these immunoblot assays.
Immunoblot assays were also performed with sera from five
cattle naturally infected with M. avium subsp. paratuberculosis
(Fig. 3A, 183, 2075, 184, 805, and 45). MAP1156 (Fig. 3A, lane
3, all panels) showed higher levels of reactivity than MAP1152
(Fig. 3A, lane 2, all panels). Furthermore, densitometry anal-
ysis (see Table S1 in the supplemental material) enabled a
semiquantitative comparison and showed that MAP1156 dis-
played 2- to 5-fold more seroreactivity than MAP1152 among
these M. avium subsp. paratuberculosis-seropositive samples.
Conversely, weak reactivity was observed with sera from cattle
experimentally infected with M. avium or M. bovis (Fig. 3B).
None of the serum samples yielded any background activity
against the LacZ antigen or the MBP tag (Fig. 3, lane 4, each
panel).
We also followed the reactivity of the proteins against serum
samples taken at different time points during natural infection.
Samples corresponded to bleeds taken 9 to 14 months apart,
corresponding to disease progression from subclinical to clin-
ical infection. Results obtained with these samples (Fig. 4)
indicated that MAP1152 did not react with any of the serum
samples (Fig. 4, upper panel, lanes 1 to 4), while MAP1156
(Fig. 4, middle panel, lanes 1 to 4) and M. avium subsp. para-
tuberculosis K-10 whole-cell extract (Fig. 4, lower panel) dis-
played increasing reactivities with samples from the subclinical
(Fig. 4, lanes 1 and 2) and clinical stages (Fig. 4, lanes 3 and 4).
FIG. 2. SDS-PAGE and immunoblot analysis of recombinant M.
avium subsp. paratuberculosis MAP1152 and MAP1156 proteins.
Shown is a 12% SDS-PAGE gel, stained with GelCode blue, along with
three corresponding immunoblots containing purified recombinant fu-
sion proteins. Antibody or serum samples used to probe the immuno-
blot are indicated beneath the panels: MBP MAb, monoclonal anti-
body against the maltose-binding protein; mouse 160, serum derived
from a mouse immunized with live M. avium subsp. paratuberculosis
cells; rabbit 273, serum derived from a rabbit immunized with live M.
avium subsp. paratuberculosis cells. Size standards, reported in kDa,
are indicated to the left. Assignments for the gel and blots were as
follows: lane 1, protein size standards; lane 2, MAP1152; lane 3,
MAP1156; lane 4, LacZ.
FIG. 3. Western blot analysis of antibody responses to MAP1152
and MAP1156 in naturally infected cattle. Immunoblots containing
MAP1152 and MAP1156 were probed with sera from five cows (183,
2075, 84, 805, and 45) naturally infected with M. avium subsp. paratu-
berculosis (A) or from two additional cows experimentally infected
with M. avium or M. bovis (B). Size standards, reported in kDa, are
indicated to the left. Assignments for the blots were as follows: lane 1,
protein size standards; lane 2, MAP1152; lane 3, MAP1156; lane 4,
LacZ.
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Both proteins reacted with the anti-MBP monoclonal antibody
control (Fig. 4, lane 5), although MAP1152 yielded a weaker
reaction.
Seroreactivity of recombinant protein with sera from M.
avium subsp. paratuberculosis-infected and noninfected cattle
by ELISA. As the ELISA technology is readily adaptable to
diagnostic applications, we also determined the reactivities of
MAP1152 and MAP1156 by this method. In addition, this
assay is generally performed to evaluate the antigen-antibody
reaction in the absence of denaturing agents. Thus, both linear
and conformational epitopes may contribute to the overall
reactivity. Due to limiting amounts of serum samples, the
ELISA was performed using archived serum samples which
were previously evaluated with the Idexx test at the University
of Nebraska—Lincoln Veterinary Diagnostic Laboratory (Ta-
ble 1).
Each sample was tested in triplicate against LacZ (negative-
control antigen) and on three different days in duplicate (day
3) or triplicate (days 1 and 2) to evaluate reproducibility and
performance against MAP1152, MAP1156, and a standard M.
avium subsp. paratuberculosis antigen control (the Idexx anti-
gen, a proprietary mixture of M. avium subsp. paratuberculosis
antigens) included in the Idexx test kit (see Table S2 in the
supplemental material). Each antigen showed low reactivity
and low variability as tested against seronegative serum sam-
ples from noninfected cattle. As expected, the differences in
mean absorbance values for samples from M. avium subsp.
paratuberculosis-infected versus noninfected cattle were statis-
tically significant for MAP1152 (P  0.01), MAP1156 (P 
0.05), and the Idexx antigen (P  0.001), with more variable
results for MAP1156 and the Idexx antigen (see Table S3 in the
supplemental material). In contrast, the difference in absor-
bance means was not significant for the LacZ negative-control
antigen carrying the MBP tag (P  0.05). However, the reac-
tivity of seropositive samples against LacZ was also more vari-
able, as indicated by the error bars in Fig. 5. With the M. avium
subsp. paratuberculosis capture antigens we were able to dif-
ferentiate, in the combined analysis, between the groups of
seropositive and seronegative samples. Thus, M. avium subsp.
paratuberculosis infection results in a humoral response di-
rected against epitopes present in MAP1152, MAP1156, and
the Idexx antigen. However, absorbance values obtained using
MAP1152 and MAP1156 as the capture antigens were lower
than those attained with the Idexx capture antigen. This per-
formance is not surprising, because these results were obtained
with the standardized Idexx test protocol.
Comparative analysis of the reactivity of each serum-antigen
combination was also carried out (Fig. 6). Reactivity trends
were similar for both MAP1152 and MAP1156, as all samples
with higher absorbance readings for MAP1152 also yielded
higher values for MAP1156. The Idexx antigen followed a
similar trend, except for the positive control, as all three M.
avium subsp. paratuberculosis antigens yielded similar absor-
bance values. In contrast, three seropositive samples (EDNA,
308, and 2010-07) yielded significantly higher absorbance val-
ues for the Idexx antigen than for MAP1152 and MAP1156.
No samples were expected to yield above-background absor-
bance readings with LacZ, the negative antigen control carry-
ing the MBP tag. However, the EDNA serum sample displayed
approximately four-times-higher absorbance readings than any
other sample.
Both statistical analysis using GLIMMIX and calculation of
S/P ratios for the Idexx antigen yielded the same classification
as the original test (see Tables S2 and S4 in the supplemental
material). Because cutoff values for S/P ratios are dependent
on the particular assay procedure, capture antigen, and selec-
tion of an appropriate positive-control serum, GLIMMIX pro-
vides the more accurate analysis for the recombinant antigens.
Absorbance means for each antigen-serum combination were
compared to each other, and samples were classified as positive
FIG. 4. Western blot analysis of antibody responses to MAP1152
and MAP1156 during the course of JD. Immunoblots of MAP1152
(upper gel), MAP1156 (middle gel), and K-10 whole-cell extract (lower
gel) were probed with serum samples withdrawn from a naturally
infected cow (cow 47) at various times during the course of the exper-
iment: lane 1, first bleed, subclinical infection; lane 2, 12 months after
first bleed, borderline clinical/subclinical infection; lane 3, 26 months
after first bleed, clinical infection; lane 4, 35 months after first bleed,
advanced clinical infection; lane 5, anti-MBP monoclonal antibody
control. Size standards (in kDa) are indicated to the left.
FIG. 5. Seroreactivities of MAP1152 and MAP1156 recombinant
proteins to infected and noninfected cattle. Antigen (0.010 mg) reac-
tivity was evaluated by ELISA against sera from cattle naturally in-
fected with M. avium subsp. paratuberculosis (filled bars) or sera from
culture-negative cattle (open bars). Each serum sample was diluted
1:25 in Idexx dilution buffer. Each column represents mean absorbance
(from triplicate measurements against LacZ; averaged from measure-
ments on three different days in duplicate or triplicate for other anti-
gens [see Table S2 of the supplemental material]) per antigen, 
standard errors of the means from noninfected cattle (left columns) or
infected cattle (right columns), as evidenced from the original classi-
fication of serum samples. Significance levels are indicated as follows:
, P  0.05; , P  0.01; , P  0.001.
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or negative based on the P value obtained for the comparison
against the negative-control serum for the corresponding test
antigen. This analysis indicated that the nonspecific MBP-
LacZ antigen control identified all samples, except EDNA, as
seronegative; in contrast, antigens MAP1152 and MAP1156
misclassified only the seropositive sample 2010-07 as seroneg-
ative (see Table S4). Thus, overall, all M. avium subsp. para-
tuberculosis antigens yielded a classification of serum samples
consistent with the original test.
DISCUSSION
Development of effective strategies for the control of JD
remains one of the most challenging issues in animal health
(15, 19). Advances in M. avium subsp. paratuberculosis genom-
ics and molecular genetics provide an integrated rational ap-
proach to solve this problem (1, 3, 29). In this context, the
search for new diagnostic tests can be most effective if com-
bined with novel approaches to vaccination and knowledge of
what the test indicates regarding the underlying mechanisms of
disease pathogenesis. Targeting of the MAP1152-MAP1156
gene cluster was based on the identification of an attenuating
mutation possibly related to the expression of this cluster and
a potential role of the encoded proteins as B- or T-cell anti-
gens. An attenuated mutant may serve as a candidate live
attenuated vaccine strain and the protein as a subunit vaccine
or diagnostic indicator; all relevant aspects are combined into
an integrated approach.
In this study, we demonstrated that both MAP1152 and
MAP1156 encode reactive B-cell epitopes, a result predicted
from the surface localization implied by in silico analysis (Table
2). This finding is also consistent with prior experimental evi-
dence on other PE/PPE proteins. For example, the M. tuber-
culosis protein Rv2430c (PE25) was identified as a strong B-
cell antigen (12), and the seroreactivity of MAP3420 c was
demonstrated in cattle (36). In contrast, antigens MAP1518
(Map41; ortholog of Rv1808 [PPE32]) and MAP3184 (Map39;
ortholog of Rv3135 [PPE50]), the M. avium strain 104 MaPE
protein, and the cell wall-associated M. tuberculosis protein
Rv3873 (PPE68) serve as T-cell antigens (35, 37, 41).
MAP1152 and related PPE proteins MAP1153 and
MAP1155 are members of the ancestral PPE sublineage IV
(22). The genes encoding these proteins belong to an ancestral
cluster that underwent duplication events from ancestral
ESAT-6 clusters but without a concomitant duplication of the
ESAT-6 genes and, thus, these paralogs are no longer associ-
ated with the ESAT-6 genes. PE/PPE genes are usually orga-
nized in operons encompassing at least several PE and/or PPE
members (46, 58). Biochemical evidence indicates that PE and
PPE function in pairwise combinations of interacting proteins
exposed to the cell surface (18, 46, 54), with the larger-sized
PPE proteins providing a pocket for the PE partner (54).
However, MAP1152 is organized in a cluster devoid of coding
sequences for PE proteins. Because the probability of PPE
proteins participating in pairwise associations decreases for
unlinked PE and PPE genes (46), the function of MAP1152
may or may not require a PE partner. Instead, MAP1152 may
play additional roles in the mechanisms of pathogenesis, as
shown for other PE/PPE proteins. For example, M. tuberculosis
transposon mutants of the PE/PPE genes Rv1807 (PPE31),
Rv3872 (PPE35), and Rv3873 (PPE68) are attenuated in mice
(49). Likewise, a transposon mutant in the M. avium PPE gene
homologous to Rv1787 (PPE25) displayed impaired growth in
macrophages, reduced virulence in mice, and failed to prevent
phagosome acidification (26, 30). Thus, a group of PE and PPE
proteins may be necessary for intracellular survival.
MAP1156 is also a B-cell antigen, with stronger reactivity
than MAP1152 in Western blot assays, a property also consis-
tent with its reactivity with immune mouse and rabbit sera and
inferred surface localization. MAP1156 belongs to the unchar-
acterized protein family UPF0089. M. tuberculosis encodes 15
members of this family, which includes proteins with triacyl-
glycerol synthase (TGS) activity (16). The M. tuberculosis ORF
Rv1425 is the closest homolog to MAP (Table 2), but this ORF
has been shown not to possess significant TGS activity, at least
under the conditions tested. One possible role consistent with
a strong humoral reaction is that this ORF “hitchhiked” with
M. avium subsp. paratuberculosis into a coexpression unit that
modulates the immune response. Microorganisms of the M.
tuberculosis complex possess a large number of PE-PGRS pro-
teins that are associated with immunoregulatory roles (4, 17).
However, as indicated above, the M. avium subsp. paratuber-
culosis evolutionary lineage separated prior to the further ex-
pansion of the ESAT-6 region V that gave rise to the PE-
PGRS and PPE-MPTR sublineage V PE/PPE proteins (22).
Thus, the absence of PE-PGRS proteins may require the re-
cruitment of other proteins, for example, MAP1156, to play
this immunomodulatory role. Future experiments will be di-
rected to identify T-cell epitopes in both MAP1152 and
MAP1156. These tests are indispensable for determining the
major roles of these antigens in immunopathogenesis. For
FIG. 6. Individual responses of serum samples from infected and
noninfected cattle to recombinant antigens. Antigen (0.010 mg) reac-
tivity was evaluated by ELISA against sera from cattle naturally in-
fected with M. avium subsp. paratuberculosis and sera from culture-
negative cattle. Each serum was diluted 1:25 in Idexx dilution buffer.
Each column represents mean absorbance (triplicate measurements
against LacZ; average measurements on three different days in dupli-
cate or triplicate for other antigens, as indicated in Table S2 of the
supplemental material) per antigen,  standard errors of the means
from noninfected () or infected () cattle, as evidenced from the
original classification of serum samples. The reaction to each antigen
is indicated (see inset for pattern key).
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example, it is possible that the PPE protein MAP1152, the
weaker B-cell antigen in Western immunoblotting analyses,
may elicit a predominant T-cell response early in infection,
with MAP1156 exerting a countermodulating B-cell response,
most favorable for M. avium subsp. paratuberculosis to main-
tain a chronic infection. This hypothesis is consistent with the
increasing MAP1156 seroreactivity observed with serum sam-
ples withdrawn as JD progressed from the subclinical to clin-
ical stage (Fig. 4). However, a more detailed study of linear
and conformational epitopes in these proteins, especially for
MAP1152, should be undertaken, as conformational epitopes
may not be reactive in Western immunoblot assays.
The B-cell reactivities of both MAP1152 and MAP1156 in
Western blot assays and the ELISA with serum samples from
M. avium subsp. paratuberculosis-infected cattle are likely as-
sociated with private rather than cross-reactive or shared
epitopes from related M. avium subsp. paratuberculosis pro-
teins. In this context, the closest paralog to MAP1152 is
MAP1518, with 47% identity. Likewise, the closest paralog to
MAP1156 is MAP1969c, with 38% identity (see Table S5 in the
supplemental material). The low degree of reactivity of
MAP1152 in the immunoblot assays against sera from M. bo-
vis-infected animals may be explained in a similar manner, as
the closest homolog (Mb1837) shares only 50% identity. In
contrast, the low reactivity of MAP1156 against the M. bovis
serum, and of MAP1152 and MAP1156 against M. avium
hominissuis serum, may be associated with low expression lev-
els in these microorganisms. Otherwise, the corresponding
proteins are highly homologous, with 86 to 99% identity (see
Table S5) and, thus, likely to be highly cross-reactive, as most
epitopes are shared. Moreover, the MAP1152-MAP11156
cluster organization is conserved between M. avium subsp.
paratuberculosis and M. avium 104 (a sequenced isolate of M.
avium subsp. hominissuis), with both genomes possessing
highly homologous genes within this region. However, se-
quence divergence with M. avium 104 occurs upstream from
MAP1152 that could affect gene regulation. Nonetheless, to
substantiate these findings for the development of diagnostic
tests, it will be necessary to test a larger group of cattle infected
with M. bovis, M. avium subspecies, and other environmental
species, such as Mycobacterium kansasii.
Interestingly, MAP1152, MAP1156, and the Idexx antigen
yielded similar absorbance values against the standardized
Idexx positive-control bovine serum included in the Idexx kit,
which is from a single naturally infected Holstein cow (Table
1). However, the other three seropositive clinical samples re-
acted more strongly with the Idexx antigen (Fig. 6). As indi-
cated above, these results may be due to methodological as-
pects, as the overall assay optimization was based on the Idexx
protocol. Alternatively, or by compounding effects, the in-
creased reactivity in these samples against the Idexx antigen
may in part reflect the presence of cross-reactive antibodies
against the various M. avium subsp. paratuberculosis proteins
present in the Idexx antigen.
In summary, M. avium subsp. paratuberculosis-infected cattle
mount a humoral response to both MAP1152 and MAP1156.
Further research is needed to determine the values of these
recombinant proteins as diagnostic capture antigens, subunit
vaccines, markers of disease progression, and their suitability
for the development of tests for diagnosis of infected from
vaccinated animals (DIVA), coupled with the development of
live attenuated deletion mutant marker vaccines (13, 59).
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